[HTML][HTML] Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course

…, M Piga, U Drott, C Delbrueck, J Bauhammer… - Journal of clinical …, 2019 - mdpi.com
Antisynthetase syndrome (ASSD) is a rare clinical condition that is characterized by the
occurrence of a classic clinical triad, encompassing myositis, arthritis, and interstitial lung …

Rituximab in the treatment of Jo1 antibody–associated antisynthetase syndrome: Anti-Ro52 positivity as a marker for severity and treatment response

J Bauhammer, N Blank, R Max, HM Lorenz… - The Journal of …, 2016 - jrheum.org
Objective. Rituximab (RTX) has been used successfully for the treatment of severe Jo1
antibody-associated antisynthetase syndrome. The aim of this retrospective study was to evaluate …

Timing of onset affects arthritis presentation pattern in antisyntethase syndrome

…, DI Perez-Roman, J Bauhammer… - Clinical and …, 2018 - iris.uniroma1.it
To evaluate if the timing of appearance with respect to disease onset may influence the arthritis
presentation pattern in antisynthetase syndrome (ASSD). METHODS: The patients were …

Nailfold capillaroscopy characteristics of antisynthetase syndrome and possible clinical associations: results of a multicenter international study

…, G Emmi, A Iuliano, J Bauhammer… - The Journal of …, 2019 - jrheum.org
Objective. To describe nailfold videocapillaroscopy (NVC) features of patients with antisynthetase
syndrome (AS) and to investigate possible correlations with clinical and serological …

Antisynthetase syndromes

J Bauhammer, C Fiehn - Zeitschrift für Rheumatologie, 2019 - Springer
Die Antisynthetasesyndrome (ASS) sind seltene Autoimmunerkrankungen. Kennzeichnend
ist das Vorhandensein mindestens eines der 3 Hauptsymptome Myositis, interstitielle …

Drug-induced osteopathy in rheumatology

C Fiehn, J Bauhammer - Zeitschrift fur Rheumatologie, 2022 - europepmc.org
Osteopathy in rheumatology can either be primary a condition as a consequence of
inflammatory rheumatic diseases but can also be drug induced. The most severe clinical …

Medikamenteninduzierte Osteopathien in der Rheumatologie

C Fiehn, J Bauhammer - Zeitschrift für Rheumatologie, 2022 - Springer
Osteopathien in der Rheumatologie können primär, als Folge einer entzündlich rheumatischen
Grunderkrankung oder aber auch medikamenteninduziert entstehen. Die gravierendsten …

TNFi is associated with positive outcome, but JAKi and rituximab are associated with negative outcome of SARS-CoV-2 infection in patients with RMD

AC Regierer, R Hasseli, M Schäfer, BF Hoyer… - RMD open, 2021 - rmdopen.bmj.com
Introduction Several risk factors for severe COVID-19 specific for patients with inflammatory
rheumatic and musculoskeletal diseases (RMDs) have been identified so far. Evidence …

Sarkopenie in der Rheumatologie

…, X Baraliakos, J Braun, J Bauhammer - Arthritis und …, 2022 - thieme-connect.com
Sarkopenie bezeichnet laut aktueller Definitionen, z. B. der durch die European Working
Group on Sarcopenia in Older People (EWGSOP) im Jahre 2019 erstellten Definition, den …

[HTML][HTML] The protective effect of tumor necrosis factor-alpha inhibitors in COVID-19 in patients with inflammatory rheumatic diseases compared to the general …

R Hasseli, F Hanses, M Stecher, C Specker… - Frontiers in …, 2024 - frontiersin.org
Objectives To investigate, whether inflammatory rheumatic diseases (IRD) inpatients are at
higher risk to develop a severe course of SARS-CoV-2 infections compared to the general …